Nitric Oxide Synthase Inhibition in Humans Reduces Cerebral Blood Flow but Not the Hyperemic Response to Hypercapnia
Author(s) -
Richard P. White,
Colin Deane,
Patrick Vallance,
Hugh S. Markus
Publication year - 1998
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/01.str.29.2.467
Subject(s) - medicine , hypercapnia , middle cerebral artery , omega n methylarginine , cerebral blood flow , nitric oxide synthase , blood flow , anesthesia , vasodilation , transcranial doppler , hemodynamics , cerebral circulation , nitric oxide , ischemia , acidosis
Animal studies suggest that nitric oxide (NO) is important in basal cerebral blood flow (CBF) regulation and that it may mediate the vasodilatory response to carbon dioxide. We investigated its role in the human circulation using the NO synthase inhibitor N(G)-monomethyl-L-arginine (L-NMMA).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom